MiRXES eyes fuss-free early cancer tests; road ahead not easy
Local startup, which is heading towards a public listing, is doubling down on its acquisition strategy after a US$77m funding round
Add BT as a preferred source
Singapore
IMAGINE if early-stage cancer testing was as fuss-free as taking a Covid PCR test or a blood test.
Homegrown startup MiRXES is hoping to bring such "liquid" cancer tests into our homes in about 5 to 10 years' time. If this dream pans out, a simple blood test could be able to detect all types of cancers at an early stage - when it is easier to treat and possibly cure.
TRENDING NOW
Singapore developer in limbo after Timor-Leste scraps major township project
Troubled platform UCars founded by group of dealers wound up on S$4 million debt
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think
